Althea Wins $100K SBIR Grant to Develop Assays for Pediatric Cancers

Oct 19, 2004

NEW YORK, Oct. 19 (GenomeWeb News) - Althea Technologies has received a $100,000 Phase I SBIR grant from the National Cancer Institute to help develop validated, quantitative gene-expression assays for multiple pediatric cancers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

What You Might Learn

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

From Whales to Urchins to Algae

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

In the Skin

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

This Week in PNAS

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.

Main menu